Back to Search
Journal ArticleUnknown

Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

Author Affiliations
International Union Against Tuberculosis and Lung Disease, Instituut voor Tropische Geneeskunde, Damien Foundation, University of Zurich, ...
Published InAmerican Journal of Respiratory and Critical Care Medicine
Year2010
Citations654

Abstract

RATIONALE: Based on expert opinion, the global guidelines for management of multidrug-resistant tuberculosis impose lengthy and often poorly tolerated treatments. OBJECTIVES: This observational study evaluates the effectiveness of standardized regimens for patients with proven multidrug-resistant tuberculosis previously untreated with second-line drugs in low-income countries. METHODS: Consenting patients were sequentially assigned to one of six standardized treatment regimens. Subsequent cohorts were treated with regimens adapted according to results in prior cohorts. The study was designed to minimize failure and default while reducing total treatment duration without increasing relapse frequency. MEASUREMENTS AND MAIN RESULTS: We report the treatment outcome of all patients with laboratory-confirmed, multidrug-resistant tuberculosis enrolled from May 1997 to December 2007. The most effective treatment regimen required a minimum of…
View at Publisher

BORR does not host full-text PDFs. The button above takes you to the original publisher.